ASTRAZENECA PLC SPON ADR EACH REP 0.50 ORD SHS (NASDAQ: AZN)

Overview
current price
$71.39
$71.39
change
-0.03 | -0.04%
-0.03 | -0.04%
Yesterday's Close
71.42
open
71.85
volume
5.72 M
30d. avg volume.
3.65 M
1 day
71.00 - 73.68
52 weeks
60.47 - 87.68
p/e
33.85
beta
0.4693
market cap
221.44 B
dividend yield
2.04%
Industry
-
News and Commentary
AstraZeneca Threatens To Move Vaccine Production Amid Reduced State Support AstraZeneca Plc (AZN&nb...
Market Update: Dow Falls 500 Points, S&P 500, Nasdaq Sink Lower Investors staged a broader market sell-off on Wednesday as underwhelming earnings reports from Alphabet and Tesla pulled the S&P 500 Index and Nasdaq Composite down to their wors...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment AstraZeneca PLC (AZN&nb...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute A Delaware federal jury has determined that AstraZeneca Plc
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, D... Thursday, AstraZeneca Plc (AZN...
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector Healthcare giants Pfizer Inc (...
AstraZeneca Pulls Plug On Vaxzevria COVID-19 Vaccine Amid Surplus of Updated Vaccines AstraZeneca (AZN 
Market Update: Dow Posts Sixth Day of Gains The Dow Jones Industrial Average rose over 170 points in its sixth straight winning session, as weakness in tech stock pulled the S&P 500 Index and Nasdaq Composite slightly lowe...
US Labor Market Heats Up In March: Payrolls Grow By 303,000, Highest In 10 Months, Dampen June Rate... The pace of expansion in the U.S. labor market exceeded forecasts last month, dampening investor hopes for potential interest rate cuts by the Federal Reserve.
Pharma Continues Its Ongoing Battle Against Cancer Last Tuesday, Pfizer Inc (PFE
StockTwits
StockTwits

Join now and unlock premium features